The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Projected To Become By 2030 Based On Its 2026 Valuation?
The pharmaceutical contract development and manufacturing organization (cmo) market size has seen rapid expansion in recent years. It is forecast to rise from $54.73 billion in 2025 to $60.7 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.9%. The historical period’s growth stemmed from factors such as increased R&D expenditures by pharmaceutical companies, a growing prevalence of chronic diseases, a rise in generic drug demand, technological progress in drug manufacturing, and a greater emphasis on preclinical and clinical research.
The pharmaceutical contract development and manufacturing organization (cmo) market is projected to experience substantial expansion over the upcoming years. By 2030, its valuation is anticipated to reach $90.76 billion, advancing at a compound annual growth rate (CAGR) of 10.6%. This anticipated growth during the forecast period stems from factors such as the increasing embrace of personalized medicine, rising demand for biologics and intricate therapeutics, the broadening of CDMO capabilities in developing regions, the incorporation of digital technologies into drug development, and a surge in strategic collaborations and mergers within the pharmaceutical sector. Key developments expected during this period involve the outsourcing of drug development and manufacturing, the diversification of CDMO service offerings, a heightened emphasis on regulatory adherence and quality assurance, forming strategic alliances between pharmaceutical companies and CDMOs, and the integration of advanced analytical and testing solutions.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2825&type=smp
Which Market Drivers Are Supporting The Expansion Of The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
The growing number of patent expirations is anticipated to drive the pharmaceutical contract development and manufacturing market. This phenomenon signifies the conclusion of the legally safeguarded exclusive rights enabling an inventor or patent holder to manufacture, market, or utilize an invention for a defined duration. Pharmaceutical contract development and manufacturing services are instrumental in the rapid creation and production of generic drugs, facilitating their entry into the market once patents expire. For example, in February 2024, according to the DrugTimes is a Chinese-based company focused on the pharmaceutical and biotech industry, by 2037, more than 25 products are predicted to lose patent protection, which could lead to a combined revenue decrease surpassing $236.4 billion, based on 2024 sales. Consequently, the escalating rate of patent expiration serves as a significant impetus for the pharmaceutical contract development and manufacturing market.
What Segment Groups Are Identified Within The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
The pharmaceutical contract development and manufacturing organization (cmo) market covered in this report is segmented –
1) By Type: Contract Manufacturing Services, Contract Research Services
2) By Research Phase: Preclinical, Phase I, Phase II, Phase III, Phase IV
3) By End User: Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies
Subsegments:
1) By Contract Manufacturing Services: Active Pharmaceutical Ingredient (API) Manufacturing, Formulation Development, Finished Dosage Form Manufacturing, Packaging Services, Supply Chain Management
2) By Contract Research Services: Preclinical Research Services, Clinical Trial Management, Regulatory Affairs Consulting, Biostatistics And Data Management, Analytical And Testing Services
What Trends Are Advancing Progress In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
Leading firms within the pharmaceutical contract development and manufacturing sector are introducing innovative services, including the DevPack, to enrich their service offerings and address the dynamic requirements of the industry. This DevPack service is designed to be optimized through collaboration with various partners, establishing a standardized dataset for development processes. For example, ASM Research Chemicals, a company based in Germany specializing in contract research and manufacturing services, unveiled DevPack in May 2023. This new development pack service is specifically engineered for the manufacturing of active pharmaceutical ingredients (APIs). The DevPack service, developed in collaboration with ten key partners, delivers a standardized dataset for development processes. Its purpose is to facilitate and expedite API research, development, and subsequent scale-up phases. This service proves highly beneficial for Contract Manufacturing Organizations (CMOs) and pharmaceutical enterprises seeking rapid early-stage manufacturing route development for APIs, concurrently offering support for analytical development and regulatory filing processes.
Which Companies Hold Significant Positions In The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market?
Major companies operating in the pharmaceutical contract development and manufacturing organization (cmo) market are Lonza Group, Catalent Inc, WuXi AppTec Inc., Recipharm AB, Almac Group, Aenova Group, Baxter International Inc, SGS Life Science Services SA, Jubilant Pharmova Ltd, Dishman Pharmaceuticals, Kemwell Pvt. Ltd., Nipro Corp., CMIC Group, Sawai Pharmaceutical Co. Ltd, IDT Australia Limited, Aurigene Pharmaceutical Services Limited, Vetter Pharma International GMBH, Consort Medical PLC, Siegfried Holding AG, Evonik Industries, NextPharma, Royal DSM N.V, HAUPT Pharma AG, Famar, OTC-PharmNEUCA, Farmacol, Polska Grupa Farmaceutyczna, Polpharma, TZMO, Eurofarma Laboratórios S.A., Ache Laboratórios Farmacêuticos S.A., Blanver Farmoquímica e Farmacêutica S.A., Prati-Donaduzzi, União Química Farmacêutica Nacional S.A, Laboratorios Richmond S.A.C.I.F., Bago S.A., Elea Laboratories S.A.C.I. y F., Gador S.A., LIFEPharma, Neopharm, Gulf Pharmaceutical Industries JULPHA, NewBridge Pharmaceuticals Limited, Aspen Pharmacare Holdings Limited, Adcock Ingram Holdings Limited, Pharma-Q (Pty) Ltd, Vital Health Foods, EIPICO (Egyptian International Pharmaceutical Industries Company), Pharco Pharmaceuticals
Read the full pharmaceutical contract development and manufacturing organization (cmo) market report here:
How Is The Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Distributed Across Key Geographic Regions?
North America was the largest region in the global pharmaceutical contract development and manufacturing market in 2025. The Middle East is expected to be the fastest-growing region in the global pharmaceutical contract development and manufacturing market during the forecast period. The regions covered in the pharmaceutical contract development and manufacturing organization (cmo) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=2825&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Contract Development And Manufacturing Organization (CMO) Market 2026, By The Business Research Company
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Market Report 2026
Topical Drugs Contract Development And Manufacturing Organization Cdmo Market Report 2026
Biopharmaceuticals Contract Manufacturing Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model